Related Experiment Videos
Angiotensin-converting enzyme inhibitors in heart failure
M Borek1, S Charlap, W H Frishman
1Department of Medicine, Long Island College Hospital, Brooklyn, New York.
The Medical Clinics of North America
|March 1, 1989
Abstract:
Recognition of the importance of the renin-angiotension-aldosterone system in heart failure, along with an appreciation of the hemodynamic benefits of vasodilator therapy has led to the widespread use of angiotensin-converting enzyme (ACE) inhibitors in the treatment of heart failure. The ACE inhibitors are the only class of vasodilator agents shown to have a significant protective effect against mortality in patients with heart failure.